Bionic Prosthetic and Orthotic Market

Bionic Prosthetic & Orthotic Market Segmentation by Type (Orthotics and Prosthetics); and by Application (General Medical & Surgical Hospitals, Rehabilitation Centres, Clinics, and Others) – Global Demand Analysis and Opportunity Outlook 2021-2029

Buy Now
Report ID: 2949 | Published On: Feb 01, 2022
  1. Introduction
    • Market Definition
    • Market Segmentation
    • Product Overview
  2. Assumptions and Acronyms
  3. Research Methodology
  4. Research Process
    • Primary Research
    • Manufacturers
    • Distributors
    • End Users
    • Secondary Research
    • Market Size Estimation
  5. Executive Summary - Global Advanced Therapy Medicinal Products Market
  6. Analysis of Market Dynamics
  7. Drivers
  8. Trends
  9. Key Market Opportunities for Business Growth
  10. Major Roadblocks for the Market Growth
  11. Regulatory & Standard Landscape
  12. Value Chain Analysis
  13. Potential ATMP Treatment Analysis
  14. Pricing Analysis of Global Advanced Therapy Medicinal Products Market
  15. Use Case Analysis
  16. Pipeline Analysis
  17. Analysis on the Manufacturing Process
  18. Analysis of COVID-19 Impact on the Global Advanced Therapy Medicinal Products Market
  19. Analysis of End-User Market Share of Global Advanced Therapy Medicinal Products
  20. Competitive Positioning
  21. Competitive Landscape
  22. Market Share Analysis of Major Players (%), 2021
  23. Competitive Benchmarking
  24. Novartis AG.
  25. Takeda Pharmaceutical Company Limited
  26. Gilead Sciences, Inc.
  27. Bluebird Bio, Inc
  28. BioMarin Pharmaceutical Inc
  29. Vericel Corporation
  30. Mallinckrodt Pharmaceuticals
  31. UniQure N.V.
  32. JCR Pharmaceuticals Co., Ltd.
  33. Spark Therapeutics, Inc. (Parent Company: Roche)
  34. Kolon TissueGene, Inc.
  35. Global Advanced Therapy Medicinal Products Market Outlook
  36. By Value (USD million)
  37. By Product
  38. CAR-T Therapy, 2021-2031F (USD million)
  39. Gene Therapy, 2021-2031F (USD million)
  40. Cell Therapy, 2021-2031F (USD million)
  41. Tissue Engineered Product, 2021-2031F (USD million)
  42. By Disease
  43. Oncology, 2021-2031F (USD million)
  44. Genetic Disorders, 2021-2031F (USD million)
  45. CNS, 2021-2031F (USD million)
  46. Dermatology, 2021-2031F (USD million)
  47. Others, 2021-2031F (USD million)
  48. By End-User
  49. Hospitals & Clinics, 2021-2031F (USD million)
  50. Research & Academic Institutes, 2021-2031F (USD million)
  51. Global Advanced Therapy Medicinal Products Market by Region
  52. North America, 2021-2031F (USD million)
  53. Europe, 2021-2031F (USD million)
  54. Asia-Pacific, 2021-2031F (USD million)
  55. Latin America, 2021-2031F (USD million)
  56. Middle East & Africa, 2021-2031F (USD million)
  57. North America Advanced Therapy Medicinal Products Market Outlook
  58. By Value (USD million)
  59. By Product
  60. CAR-T Therapy, 2021-2031F (USD million
  61. Gene Therapy, 2021-2031F (USD million)
  62. Cell Therapy, 2021-2031F (USD million)
  63. Tissue Engineered Product, 2021-2031F (USD million)
  64. By Disease
  65. Oncology, 2021-2031F (USD million)
  66. Genetic Disorders, 2021-2031F (USD million)
  67. CNS, 2021-2031F (USD million)
  68. Dermatology, 2021-2031F (USD million)
  69. Others, 2021-2031F (USD million)
  70. By End-User
  71. Hospitals & Clinics, 2021-2031F (USD million)
  72. Research & Academic Institutes, 2021-2031F (USD million)
  73. By Country
  74. US, 2021-2031F (USD million)
  75. Canada, 2021-2031F (USD million)
  76. Europe Advanced Therapy Medicinal Products Market Outlook
  77. By Product
  78. By Disease
  79. By End User
  80. By Country
  81. UK, 2021-2031F (USD Million)
  82. Germany, 2021-2031F (USD Million)
  83. France, 2021-2031F (USD Million)
  84. Italy, 2021-2031F (USD Million)
  85. Spain, 2021-2031F (USD Million)
  86. Russia, 2021-2031F (USD Million)
  87. Netherlands, 2021-2031F (USD Million)
  88. Rest of Europe, 2021-2031F (USD Million)
  89. Asia Pacific Advanced Therapy Medicinal Products Market Outlook
  90. By Product
  91. By Disease
  92. By End User
  93. By Country
  94. China, 2021-2031F (USD Million)
  95. India, 2021-2031F (USD Million)
  96. Japan, 2021-2031F (USD Million)
  97. South Korea, 2021-2031F (USD Million)
  98. Singapore, 2021-2031F (USD Million)
  99. Australia, 2021-2031F (USD Million)
  100. Rest of Asia-Pacific, 2021-2031F (USD Million)
  101. Latin America Advanced Therapy Medicinal Products Market Outlook
  102. By Product
  103. By Disease
  104. By End User
  105. By Country
  106. Brazil, 2021-2031F (USD Million)
  107. Argentina, 2021-2031F (USD Million)
  108. Mexico, 2021-2031F (USD Million)
  109. Rest of Latin America, 2021-2031F (USD Million)
  110. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook
  111. By Product
  112. By Disease
  113. By End User
  114. By Country
  115. GCC, 2021-2031F (USD Million)
  116. Israel, 2021-2031F (USD Million)
  117. South Africa, 2021-2031F (USD Million)
  118. Rest of Middle East & Africa, 2021-2031F (USD Million)

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.


In The News


Bionic Prosthetic & Orthotic Market Highlights 2020-2029

The bionic prosthetics & orthotics market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2021-2029. Increase in geriatric population across the world, along with the growing investment in the development of advanced technologies are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as rise in prevalence of diseases such as vascular diseases, diabetes and osteoarthritis, increase in rate of road accidents and sports injuries amongst individuals on a global level. According to the data published by United Nations, the number of people aged 60 or over is anticipated to more than double by 2050, by 962 million in 2017 to 2.1 billion in 2050 across the world.

Bionic-Prosthetics-and-Orthotics-Market

The market is segmented based on type into prosthetics and orthotics. The orthotic segment is further segmented into lower limb, upper limb and spinal orthotics. Prosthetics, on the other hand, includes upper extremity and lower extremity prosthetics, liners, sockets and modular components. The orthotics segment is anticipated to grab the largest share by the end of 2021 on account of increased prevalence of osteoarthritis and penetration of orthopaedic technology. Moreover, there has been an increase in the incidence of sports injuries, which is also projected to contribute to the growth of the segment during the forecast period. CLICK TO DOWNLOAD SAMPLE REPORT

On the basis of application, the general medical & surgical hospitals segment in the bionic prosthetics & orthotics market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that bionic prosthetic & orthotic implant is a relatively rare occurrence and as a result, a considerable portion of the population with this requirement on a global level tend to choose healthcare facilities specializing in its treatment.


Bionic Prosthetics & Orthotics Market Regional Synopsis

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia pacific is predicted to grow at the highest CAGR over the forecast period due to rise in number of road accidents and increase in diabetes-related amputations. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue because of well-established and well equipped healthcare infrastructure and rise in research and development activities. Along with this, North America also leads in terms of favourable reimbursement policies, which is also expected to contribute to the market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the bionic prosthetics & orthotics market on account of technology advancements in the field of orthopaedic prosthetics design and growth in rate of manufacturing in the region. A recent project by European Agency for Safety and Health at Work (EUOSHA) found that the burden of work injuries is 3.30% of European GDP.

Bionic-Prosthetics-Orthotics-Market-Share

The bionic prosthetics & orthotics market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis


Market Segmentation

Our in-depth analysis of the bionic prosthetics & orthotics market includes the following segments:

By Type

  • Orthotics
  • Prosthetics

By Application

  • General Medical & Surgical Hospitals
  • Rehabilitation Centers
  • Clinics
  • Others

Growth Drivers

  • Increasing Geriatric Population in the World
  • Growing investment in the development of advanced technologies

Challenges

  • Entry barriers in terms of Regulatory Guidelines
  • Shortage of well-equipped rehabilitation centers


Bionic-Prosthetics-and-Orthotics-Market
Get more information on this report: Request Sample PDF

Bionic-Prosthetics-Orthotics-Market-Share
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • Ossur Corporate
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Zimmer Biomet
    • Blatchford Inc.
    • Fillauer LLC
    • Boston Orthotics and Prosthetics
    • Ohio Willow Wood Company
    • Ultraflex Systems Inc.
    • Howard Orthopedics Inc.
    • Touch Bionics Inc.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the bionic prosthetic and orthotic market?

Ans: Increasing elderly population and growing investment in the development of advanced technologies are the key factors driving market growth.

2) What would be the CAGR of bionic prosthetic and orthotic market over the forecast period?

Ans: The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

3) What are the challenges affecting the bionic prosthetic and orthotic market growth?

Ans: Entry barriers in terms of Regulatory Guidelines and Shortage of well-equipped rehabilitation centers are the challenges affecting the growth of this market.

4) Which region will provide more business opportunities for growth of bionic prosthetic and orthotic market in future?

Ans: The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about bionic prosthetics & orthotics market.

5) Who are the major players dominating the bionic prosthetic and orthotic market?

Ans: The major players dominating the bionic prosthetics & orthotics market are Ossur Corporate, Zimmer Biomet, Blatchford Inc., and Fillauer LLC among others.

6) How are the company profiles selected?

Ans: The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the bionic prosthetics & orthotics market?

Ans: The market is segmented by type, application and region.

8) Which segment under the application segment captures the largest market size in the bionic prosthetics & orthotics market?

Ans: With respect to application, the general medical and surgery hospitals segment is anticipated to hold the largest market share as bionic prosthetic & orthotic implant is a relatively rare occurrence and as a result, a considerable portion of the population with this requirement on a global level tend to choose healthcare facilities specializing in its treatment.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample